Intersect Ent Stock Price, News & Analysis
Company Description
Intersect Ent (NASDAQ: XENT) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $954.9M.
XENT stock has gained 60.3% over the past year.
This page provides a comprehensive overview of XENT stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Intersect Ent (XENT) stock. Over the past 12 months, the stock has gained 60.3%. At a market capitalization of $954.9M, XENT is classified as a small-cap stock with approximately 33.8M shares outstanding.
Latest News
Intersect Ent has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include management, earnings, acquisition, conferences. View all XENT news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
XENT Company Profile & Sector Positioning
Intersect Ent (XENT) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing XENT often look at related companies in the same sector, including Inmode Ltd. (INMD), Iradimed Corp (IRMD), Tandem Diabetes (TNDM), Beta Bionics, Inc. (BBNX), and Establishment Labs Hldgs Inc (ESTA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate XENT's relative position within its industry.